ArticleProceedings of the National Academy of Sciences of the United States of America2004

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses.

David C Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.